適應症
供實驗室用以在Ventana自動免疫組織化學切片染色機上半定量檢測經福馬林固定、石蠟包埋的正常及腫瘤組織內的HER2抗原,對於考慮以賀癌平(Herceptin)治療的乳癌病患之評估,此一級抗體可作為一個輔助工具之用。  
劑型
 
包裝
# 790-2991:50 tests 
許可證字號
衛部藥製字第020367號 
註銷狀態
註銷日期
 
註銷理由
 
有效日期
2029-08-25  
發證日期
2009-08-25  
許可證種類
09 
中文品名
羅氏人類上皮因子接受體第二蛋白兔子單株一級抗體 
英文品名
Roche PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody 
藥品類別
B 血液學及病理學裝置 
申請商地址
臺北市中山區民權東路3段2號10樓 
通關簽審文件編號
DHA00602036703 
資料更新時間
 
製造商
名稱 廠址 公司地址 國別 製程
VENTANA MEDICAL SYSTEMS, INC 1910 INNOVATION PARK DRIVE TUCSON, AZ85755 USA US
成份表
處方標示 成分名稱 含量 單位
1 PATHWAY anti-HER-2/neu (4B5) Primary Antibody contains sufficient reagent for 50 tests.\n1-5 ml dispenser PATHWAY anti-HER-2/neu (4B5) Primary Antibody contains approximately 30 ug of a rabbit monoclonal antibody directed against human c-erbB-2 antigen.
1 The antibody is diluted in 0.05 M Tris buffered saline, 0.01 M EDTA, 0.05% Brij-35 with 0.3% carrier protein and 0.05% sodium azide, a preservative. There is trace fetal calf serum, approximately 0.25%, present from the stock solution.
1 Total protein concentration of the reagent is approximately 16 mg/ml. Specific antibody concentration is approximately 6 ug/ml. PATHWAY anti-HER-2/neu (4B5) Primary Antibody is a rabbit lgG diluted from tissue culture supernatants. There is no known irrelevant antibody reactivity observed in this product.